NCT05853146View on ClinicalTrials.gov

Fetal Heart Rate Characterization Using Innovative Advanced Non-invasive Technology

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Fetus Pulse Monitoring
Interventions
DEVICE

Oxitone 1000M

World's First FDA-cleared Wrist-Sensor Pulse Oximetry Monitor

Sponsors
All Listed Sponsors
lead

Oxitone Medical Ltd.

INDUSTRY

NCT05853146 - Fetal Heart Rate Characterization Using Innovative Advanced Non-invasive Technology | Biotech Hunter | Biotech Hunter